Abstract
Purpose
This study aims to investigate genomic imbalance in euploid products of conceptions (POCs) detected by chromosomal microarray analysis (CMA) and its association with clinical characteristics.
Methods
In a retrospective cohort study where all women with singleton pregnancy losses underwent CMA detection of POCs, only patients with euploid POCs were included in the analysis. The clinical features were compared between those with and without a copy number variant (CNV). The pathogenic CNVs and the variant of uncertain significance (VOUS) were analyzed, and the common pathogenic CNVs and uniparental disomy (UPD) were investigated.
Results
A total of 610 POCs were detected as chromosomal euploid, of which 176 were euploid with CNVs and 434 were euploid without CNVs. Regarding maternal age, gestational age, and history of pregnancy loss, no significant differences were found between the two groups. Furthermore, 104 pathogenic CNVs were identified in 93 POCs, and the deletion of 8p23.3 was found in 10 subjects. All CNVs greater than 3 Mb and 39.5% of CNVs ranging from 1 to 2 Mb were pathogenic, and only 3 CNVs < 1 Mb were pathogenic. UPD was detected in 12 POCs.
Conclusion
Besides aneuploidy, 15.24% pregnancy loss might have an association with pathogenic genomic imbalance, and the occurrence of genomic imbalance is not related to clinical characteristics. CNVs greater than 3 Mb in pregnancy losses have a high probability to be pathogenic, and approximately 40% of CNVs ranging from 1 to 2 Mb are pathogenic. The deletion of 8p23.3 is the most common pathogenic CVN in POCs of Chinese-Han women. The clinical significance of UPD in pregnancy loss needs further study.
Similar content being viewed by others
Data availability
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
References
Zinaman MJ, Clegg ED, Brown CC, O’Connor J, Selevan SG. Estimates of human fertility and pregnancy loss. Fertil Steril. 1996;65(3):503–9.
RPL EGGo, Bender AR, Christiansen OB, Elson J, Kolte AM, Lewis S, et al.: ESHRE guideline: recurrent pregnancy loss. Hum Reprod Open. 2018; 2018(2): hoy004.
Practice Committee of the American Society for Reproductive M: Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012; 98(5): 1103–1111.
Wang Y, Li Y, Chen Y, Zhou R, Sang Z, Meng L, et al. Systematic analysis of copy-number variations associated with early pregnancy loss. Ultrasound Obstet Gynecol. 2020;55(1):96–104.
Gu C, Li K, Li R, Li L, Li X, Dai X, et al. Chromosomal aneuploidy associated with clinical characteristics of pregnancy loss. Front Genet. 2021;12: 667697.
Grande M, Borrell A, Garcia-Posada R, Borobio V, Munoz M, Creus M, et al. The effect of maternal age on chromosomal anomaly rate and spectrum in recurrent miscarriage. Hum Reprod. 2012;27(10):3109–17.
Hillman SC, Pretlove S, Coomarasamy A, McMullan DJ, Davison EV, Maher ER, et al. Additional information from array comparative genomic hybridization technology over conventional karyotyping in prenatal diagnosis: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2011;37(1):6–14.
Dhillon RK, Hillman SC, Morris RK, McMullan D, Williams D, Coomarasamy A, et al. Additional information from chromosomal microarray analysis (CMA) over conventional karyotyping when diagnosing chromosomal abnormalities in miscarriage: a systematic review and meta-analysis. BJOG. 2014;121(1):11–21.
Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, et al. Global variation in copy number in the human genome. Nature. 2006;444(7118):444–54.
Hurles ME, Dermitzakis ET, Tyler-Smith C. The functional impact of structural variation in humans. Trends Genet. 2008;24(5):238–45.
Goldstein M, Svirsky R, Reches A, Yaron Y. Does the number of previous miscarriages influence the incidence of chromosomal aberrations in spontaneous pregnancy loss? J Matern Fetal Neonatal Med. 2017;30(24):2956–60.
Hardy K, Hardy PJ, Jacobs PA, Lewallen K, Hassold TJ. Temporal changes in chromosome abnormalities in human spontaneous abortions: results of 40 years of analysis. Am J Med Genet A. 2016;170(10):2671–80.
Kotzot D. Prenatal testing for uniparental disomy: indications and clinical relevance. Ultrasound Obstet Gynecol. 2008;31(1):100–5.
Fritz B, Aslan M, Kalscheuer V, Ramsing M, Saar K, Fuchs B, et al. Low incidence of UPD in spontaneous abortions beyond the 5th gestational week. Eur J Hum Genet. 2001;9(12):910–6.
Doubilet PM, Benson CB, Bourne T, Blaivas M. Society of Radiologists in Ultrasound Multispecialty Panel on early first trimester diagnosis of M, exclusion of a viable intrauterine P: diagnostic criteria for nonviable pregnancy early in the first trimester. Ultrasound Q. 2014;30(1):3–9.
Diego-Alvarez D, Garcia-Hoyos M, Trujillo MJ, Gonzalez-Gonzalez C, Rodriguez de Alba M, Ayuso C, et al. Application of quantitative fluorescent PCR with short tandem repeat markers to the study of aneuploidies in spontaneous miscarriages. Hum Reprod. 2005;20(5):1235–43.
Nagan N, Faulkner NE, Curtis C, Schrijver I. Committee MCCGWGotAfMPCP: Laboratory guidelines for detection, interpretation, and reporting of maternal cell contamination in prenatal analyses a report of the association for molecular pathology. J Mol Diagn. 2011;13(1):7–11.
Kearney HM, Thorland EC, Brown KK, Quintero-Rivera F, South ST. Working Group of the American College of Medical Genetics Laboratory Quality Assurance C: American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genet Med. 2011;13(7):680–5.
Riggs ER, Andersen EF, Cherry AM, Kantarci S, Kearney H, Patel A, et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020;22(2):245–57.
Colley E, Hamilton S, Smith P, Morgan NV, Coomarasamy A, Allen S. Potential genetic causes of miscarriage in euploid pregnancies: a systematic review. Hum Reprod Update. 2019;25(4):452–72.
Pauta M, Grande M, Rodriguez-Revenga L, Kolomietz E, Borrell A. Added value of chromosomal microarray analysis over karyotyping in early pregnancy loss: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;51(4):453–62.
Wang Y, Cheng Q, Meng L, Luo C, Hu H, Zhang J, et al. Clinical application of SNP array analysis in first-trimester pregnancy loss: a prospective study. Clin Genet. 2017;91(6):849–58.
Chen L, Wang L, Tang F, Zeng Y, Yin D, Zhou C, et al. Copy number variation sequencing combined with quantitative fluorescence polymerase chain reaction in clinical application of pregnancy loss. J Assist Reprod Genet. 2021;38(9):2397–404.
Morikawa M, Yamada H, Kato EH, Shimada S, Yamada T, Minakami H. Embryo loss pattern is predominant in miscarriages with normal chromosome karyotype among women with repeated miscarriage. Hum Reprod. 2004;19(11):2644–7.
Ogasawara M, Aoki K, Okada S, Suzumori K. Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril. 2000;73(2):300–4.
Hurles M. Gene duplication: the genomic trade in spare parts. PLoS Biol. 2004;2(7):E206.
Uddin M, Tammimies K, Pellecchia G, Alipanahi B, Hu P, Wang Z, et al. Brain-expressed exons under purifying selection are enriched for de novo mutations in autism spectrum disorder. Nat Genet. 2014;46(7):742–7.
Sheng YR, Hou SY, Hu WT, Wei CY, Liu YK, Liu YY, et al.: Characterization of copy-number variations and possible candidate genes in recurrent pregnancy losses. Genes (Basel) 2021;12(2).
Sato T, Migita O, Hata H, Okamoto A, Hata K. Analysis of chromosome microstructures in products of conception associated with recurrent miscarriage. Reprod Biomed Online. 2019;38(5):787–95.
Founds SA, Stolz DB. Gene expression of four targets in situ of the first trimester maternal-fetoplacental interface. Tissue Cell. 2020;64: 101313.
Gu C, Gao H, Li K, Dai X, Yang Z, Li R, Wen C, He Y. Copy number variation analysis of euploid pregnancy loss. Front Genet. 2022;13: 766492.
Shaffer LG, Bejjani BA. A cytogeneticist’s perspective on genomic microarrays. Hum Reprod Update. 2004;10(3):221–6.
Sahoo T, Dzidic N, Strecker MN, Commander S, Travis MK, Doherty C, et al. Comprehensive genetic analysis of pregnancy loss by chromosomal microarrays: outcomes, benefits, and challenges. Genet Med. 2017;19(1):83–9.
Zarrei M, MacDonald JR, Merico D, Scherer SW. A copy number variation map of the human genome. Nat Rev Genet. 2015;16(3):172–83.
Devriendt K, Matthijs G, Van Dael R, Gewillig M, Eyskens B, Hjalgrim H, et al.: Delineation of the critical deletion region for congenital heart defects, on chromosome 8p23.1. Am J Hum Genet. 1999;64(4): 1119-1126
Barber JC, Maloney VK, Huang S, Bunyan DJ, Cresswell L, Kinning E, et al. 8p23.1 duplication syndrome; a novel genomic condition with unexpected complexity revealed by array CGH. Eur J Hum Genet. 2008;16(1):18–27.
Habhab W, Mau-Holzmann U, Singer S, Riess A, Kagan KO, Gerbig I, et al.: Pre- and postnatal findings in a patient with a recombinant chromosome rec(8)(qter-->q21.11::p23.3-->qter) due to a paternal pericentric inversion inv(8)(p23.3q21.11) and review of the literature. Am J Med Genet A 2020;182(11): 2680-2684
Yamazawa K, Ogata T, Ferguson-Smith AC. Uniparental disomy and human disease: an overview. Am J Med Genet C Semin Med Genet. 2010;154C(3):329–34.
Benn P. Uniparental disomy: origin, frequency, and clinical significance. Prenat Diagn. 2021;41(5):564–72.
Acknowledgements
We thank all patients who paid their antenatal care in our hospital and all physicians who recorded the data on pregnancies and pregnancy outcomes.
Funding
The study was supported by a grant from the Guangzhou Women and Children’s Medical Center, Guangzhou, China (1600067–04), and a grant from the Guangzhou Municipal Science and Technology Bureau, Guangzhou, China (202102010311). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Contributions
CG and YH contributed to the conception of the study and drafted the manuscript. CG and KL contributed to the design of the research and control of the data quality. RL and LL contributed to data management and prepared the retrospective data for analysis. HG preform the bioinformatics analysis. All authors reviewed, read, and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics statement
The studies involving human participants were reviewed and approved by the Ethical Committee of the Guangzhou Women and Children’s Medical Center (2020–15001). The patients provided their written informed consent to participate in this study.
Conflict of interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Below is the link to the electronic supplementary material.
About this article
Cite this article
Gu, C., Li, K., Li, L. et al. Genomic imbalance in euploid pregnancy loss. J Assist Reprod Genet 39, 2115–2124 (2022). https://doi.org/10.1007/s10815-022-02527-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-022-02527-8